Key facts
- Neuranics’s last known valuation is $16.5M (Mar 2025).
- It has raised $10.8M.
- Notable investors include Scottish Enterprise, Old College Capital, Blackfinch Ventures, Archangel Investors, Creator Fund — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Neuranics
- ·The full record, as it builds
Funding rounds
No funding rounds for Neuranics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Neuranics
Developer of advanced tunneling magnetoresistance (TMR) quantum sensors designed to enable ultra-sensitive, low-power biomagnetic detection for wearable and healthcare applications. The company offers proprietary sensor technology with high sensitivity and low energy consumption, allowing medical device manufacturers and consumer electronics developers to achieve enhanced precision in biomagnetic monitoring.
- Sector
- Information Technology
- HQ
- Glasgow, United Kingdom
- Founded
- 2021
- Employees
- 25
- Website
- neuranics.com/
- Ownership
- Privately Held (backing)
Neuranics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Neuranics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Neuranics in its N-PORT filings yet. We sweep new filings monthly.